Connect with us

Hi, what are you looking for?

Health

BioRestorative’s BRTX-100 Shows Promise in Chronic Pain Trial

BioRestorative Therapies, a company focused on regenerative medicine, has marked a significant milestone with its product candidate BRTX-100 in the fight against chronic lower back pain. The firm completed a phase 2 clinical trial for chronic lumbar disc disease (cLDD), and CEO Lance Alstodt shared insights during a recent interview on Benzinga’s All-Access platform.

The results from the first 36 participants in the trial were promising. Alstodt reported that over 74% of individuals exhibited a greater than 50% improvement in functional ability, while more than 72% experienced a similar reduction in pain levels. These outcomes significantly surpassed the 30% percent improvement threshold established by the U.S. Food and Drug Administration (FDA). Alstodt emphasized that these results pave the way for a pivotal trial, which could expedite the approval process for BRTX-100.

Innovative Approach to Pain Management

BRTX-100 is an autologous stem cell therapy designed to address the underlying causes of chronic pain rather than merely alleviating symptoms, as is common with opioid medications and other injectable treatments. The therapy involves harvesting a patient’s stem cells, which are then cultured and injected directly into the affected disc to promote healing.

Alstodt highlighted the distinct nature of BRTX-100, asserting, “We are not just masking the pain. Our focus is on targeting the root cause.” This fundamental difference in approach could change the landscape of chronic pain treatment, offering hope to those suffering from debilitating conditions.

The phase 2 trial aims to enroll a total of 99 patients, with Alstodt indicating that recruitment is progressing well. An announcement regarding enrollment updates is expected in the near future.

Expansion and Future Prospects

In the Benzinga interview, Alstodt also discussed BioRestorative’s broader expansion plans and what lies ahead for the company. The potential for BRTX-100 reflects a growing trend in regenerative therapies that seek to utilize the body’s own resources for healing. As the company moves towards the next stages of development, the impact of these therapies on chronic pain management could be substantial.

With BRTX-100’s results setting a positive precedent, BioRestorative Therapies is poised to contribute significantly to the field of regenerative medicine, particularly for those grappling with chronic conditions. The ongoing developments will be closely watched by both the medical community and potential investors.

For those interested, the full interview with Lance Alstodt offers deeper insights into BioRestorative’s innovative strategies and future directions.

You May Also Like

Technology

Tesla (TSLA) recently reported a year-over-year drop in second-quarter deliveries, yet the market responded with optimism, pushing the stock up by 5%. This unexpected...

Technology

In a bold reimagining of the DC Universe, director James Gunn has introduced a significant narrative element in his latest film, which reveals that...

Science

Look out, daters: a new toxic relationship trend is sweeping through the romantic world, leaving many baffled and heartbroken. Known as “Banksying,” this phenomenon...

Health

The All England Lawn Tennis Club in London experienced its hottest-ever opening day on Monday, as the prestigious Wimbledon tournament kicked off under unprecedented...

Technology

Former Speaker of the House Nancy Pelosi has recently made headlines with her latest investment in the tech sector. According to official filings, she...

Entertainment

Netflix’s eagerly anticipated talent competition Building the Band is set to premiere on July 9, promising an emotional journey for viewers. This series, centered...

Entertainment

A new documentary series titled “Animals on Drugs” is set to premiere on the Discovery Channel on July 28, 2023. The three-part series follows...

World

The first dose of the hepatitis B vaccine is recommended at birth, a practice that has come under scrutiny following recent comments by Health...

Sports

ZAGREB, Croatia — A concert by Marko Perkovic, a right-wing Croatian singer known for his controversial views, attracted tens of thousands of fans to...

Business

Erin Dana Lichy, a prominent cast member of “Real Housewives of New York,” has officially settled into her dream home, a grand townhouse located...

Lifestyle

The upcoming TRNSMT 2025 festival is set to take place from July 7 to July 9, 2025, at Glasgow Green, and organizers have released...

Politics

Billionaire hedge fund manager Bill Ackman faced significant backlash following his professional tennis debut at the Hall of Fame Open in Newport, Rhode Island,...

World

CHONBURI, Thailand — The world-famous pygmy hippo, Moo Deng, celebrated her first birthday on Thursday at Thailand’s Khao Kheow Open Zoo. Despite her burgeoning...

Sports

As the summer of 2025 unfolds, the video game industry is set to deliver a diverse array of new releases that promise to captivate...

World

In Kerr County, Texas, the looming threat of flash flooding has been a persistent concern for local officials. Years before devastating floods claimed over...

Technology

Meta has officially opened preorders for its new Oakley smart glasses, the limited edition HSTN, ahead of their anticipated release on July 22, 2023....

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.